La prochaine rencontre, qui aura lieu le 10 novembre à Mila, permettra d'explorer comment pouvons-nous collectivement développer, encadrer et déployer des systèmes agentiques performants, fiables et sécuritaires en connectant chercheur·euse·s académiques, expert·e·s industriel·le·s et praticien·ne·s.
Les inscriptions sont ouvertes pour notre programme de 4 mois à temps plein, à Mila, conçu spécifiquement pour les fondateurs et fondatrices de la deep tech issus de parcours d'élite en STIM. Vous avez jusqu'au 21 novembre 2026 pour appliquer!
Le processus de demandes de supervision à Mila est maintenant ouvert! Vous pouvez appliquer dès maintenant à la maitrise de recherche ou Doctorat et joindre notre grande communauté de chercheur·euse·s à Mila pour l’automne 2027. Date limite : 1er décembre 2026
Nous utilisons des témoins pour analyser le trafic et l’utilisation de notre site web, afin de personnaliser votre expérience. Vous pouvez désactiver ces technologies à tout moment, mais cela peut restreindre certaines fonctionnalités du site. Consultez notre Politique de protection de la vie privée pour en savoir plus.
Paramètre des cookies
Vous pouvez activer et désactiver les types de cookies que vous souhaitez accepter. Cependant certains choix que vous ferez pourraient affecter les services proposés sur nos sites (ex : suggestions, annonces personnalisées, etc.).
Cookies essentiels
Ces cookies sont nécessaires au fonctionnement du site et ne peuvent être désactivés. (Toujours actif)
Cookies analyse
Acceptez-vous l'utilisation de cookies pour mesurer l'audience de nos sites ?
Lecteur Multimédia
Acceptez-vous l'utilisation de cookies pour afficher et vous permettre de regarder les contenus vidéo hébergés par nos partenaires (YouTube, etc.) ?
Revisiting the genetic support of leukotriene pathway drug targets in atherosclerotic cardiovascular disease
Tristan St-Laurent
Julien St.-Pierre
Julien Quang Le Van
Marc‐André Legault
Arachidonate 5-lipoxygenase (5-LO) and its activating protein, encoded by ALOX5 and ALOX5AP respectively, are two leukotriene pathway protei… (voir plus)ns suspected to play a role in atherosclerotic cardiovascular disease (ASCVD) through inflammatory mechanisms. Prior genetic association studies linking ALOX5 and ALOX5AP to ASCVD have motivated clinical trials of 5-LO inhibitors, such as atreleuton, which was associated with reduced atherosclerotic plaque progression in patients with a recent acute coronary syndrome in a phase II trial. However, the effect of 5-LO inhibition on ASCVD clinical outcomes remains unclear. Using data from the UK Biobank, we revisit previously reported genetic associations of ALOX5 and ALOX5AP with ASCVD using a multi-ancestry meta-analysis including data from 378,962 participants. We characterize ancestral differences in previously studied ALOX5 and ALOX5AP polymorphisms which could have led to population stratification. When adequately accounting for ancestry, these previous associations were not replicated. In addition to our replication efforts, we used association scans and transcriptome-wide association studies to test the involvement of leukotriene pathway genes with ASCVD. Overall, our results do not support a role for genetic variation in ALOX5 or its activating protein in ASCVD risk.
In Mendelian randomization (MR) studies, genetic variants are used as instrumental variables (IVs) to investigate causal relationships betwe… (voir plus)en exposures and outcomes based on observational data. However, numerous genetic studies have shown the pervasive pleiotropy of genetic variants, meaning that many, if not most, variants are associated with multiple traits, potentially violating the core assumptions of IV estimation. Uncorrelated pleiotropy occurs when genetic variants have a direct effect on the outcome that is not mediated by the exposure, while correlated pleiotropy occurs when genetic variants affect the exposure and outcome via shared heritable confounders. In this work, we propose a novel MR method, called MR-Quantile, based on weighted quantile regression (WQR) that is robust to both correlated and uncorrelated pleiotropy. We propose a procedure for selecting the optimal quantile of the ratio estimates through a likelihood-based formulation of WQR using the asymmetric Laplace distribution. Monte Carlo simulations demonstrate the empirical performance of the proposed method, especially in settings with many invalid IVs with weak pleiotropic effects. Finally, we apply our method to study the causal effect of resting heart rate on atrial fibrillation. Genetic variants associated with heart rate were identified in a genome-wide association study of 425,748 individuals from the VA Million Veteran Program, and used as instruments in a two-sample MR analysis with summary statistics from a genetic meta-analysis of 228,926 AF cases across eight studies.